Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Commercial services tags : Positive save search
Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-27 (Crawled : 11:00) - globenewswire.com
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: 7.63%
H: 3.33%
C: -4.51%
year positive financial results
Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide
Published: 2023-11-30 (Crawled : 00:00) - biospace.com/
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: 1.28%
H: 5.68%
C: -0.32%
obesity momentum positive topline trial results phase 2
ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer
Published: 2023-10-03 (Crawled : 10:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
ALXO M | $15.6 -0.89% -0.9% 480K
|
Commercial Services
|
| O: 68.19%
H: 2.84%
C: -7.17%
aspen-06 positive cancer treatment trial results
S&P CORELOGIC CASE-SHILLER INDEX POSITIVE MOMENTUM CONTINUES IN JUNE
Published: 2023-08-29 (Crawled : 13:30) - prnewswire.com
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
|
| O: -0.21%
H: 0.93%
C: 0.74%
corelogic index momentum positive
4 in 10 Workers Believe Generative AI Will Have a Positive Impact on Their Career
Published: 2023-08-22 (Crawled : 12:00) - prnewswire.com
RHI | $70.23 0.96% 0.0% 1.2M
|
Commercial Services
|
| O: -0.05%
H: 1.19%
C: 0.25%
believe positive impact
LM Funding America, Inc. Achieves Over 1,260% Year-Over-Year Revenue Growth to $3.2 Million and Generates Positive Core EBITDA for the Second Quarter of 2023
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
LMFA | $2.79 4.49% 4.3% 70K
|
Commercial Services
|
| O: 2.03%
H: 0.0%
C: -13.36%
positive funding growth
GSE Engineering Shows Positive Momentum with Over $1M in Recent New Nuclear Programs Service & Support Wins
Published: 2023-05-25 (Crawled : 13:00) - prnewswire.com
GVP | $2.69 6.75% 6.32% 29K
|
Commercial Services
|
| O: 1.12%
H: 0.0%
C: -5.36%
service nuclear momentum positive
Altimmune Announces Positive Results from Week 24 Interim Analysis of Pemvidutide MOMENTUM Phase 2 Obesity Trial and 12-Week Phase 1b Type 2 Diabetes Safety Trial
Published: 2023-03-21 (Crawled : 14:20) - biospace.com/
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -37.27%
H: 1.31%
C: -27.74%
obesity momentum positive week trial diabetes results
Hitachi Receives Positive Rating in 2023 Gartner® Vendor Rating Report for Second Consecutive Year
Published: 2023-02-08 (Crawled : 18:00) - prnewswire.com
IT | $440.38 -2.05% 0.0% 450K
|
Commercial Services
|
| O: -0.45%
H: 0.34%
C: -1.37%
gartner report year positive
Altimmune Announces Positive Topline Results from 24-Week (12-Week Extension) Trial of Pemvidutide in Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD)
Published: 2022-12-20 (Crawled : 12:20) - globenewswire.com
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -4.19%
H: 21.16%
C: 21.06%
liver disease topline trial positive results
OpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection Panel
Published: 2022-12-13 (Crawled : 13:00) - ir.opgen.com
OPGN A | $0.6299 2.24% 2.19% 80K
|
Commercial Services
|
| O: 96.32%
H: 84.47%
C: -5.87%
trial positive infection
LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data
Published: 2022-07-25 (Crawled : 15:00) - adnas.com
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: 1.32%
H: 0.0%
C: -11.42%
animal positive
Applied DNA Biotherapeutics Subsidiary LineaRx and EvviVax Publish Additional Positive Animal Proof-of-Concept Data Supporting LinearDNA™ Platform as a Unique Approach to Veterinary DNA Vaccine Development
Published: 2022-07-25 (Crawled : 13:00) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: 1.32%
H: 0.0%
C: -11.42%
veterinary vaccine dna unique animal positive platform
Protiviti Sees Positive Impact of Golf Brand Ambassador Program On and Off the Course
Published: 2022-06-22 (Crawled : 23:00) - prnewswire.com
RHI | $70.23 0.96% 0.0% 1.2M
|
Commercial Services
|
| O: -4.08%
H: 1.09%
C: -2.29%
program positive
Infor Positioned as a Leader, for the Fourth Consecutive Time, in Gartner® Magic Quadrant™ for Multienterprise Supply Chain Business Networks
Published: 2022-06-07 (Crawled : 19:00) - prnewswire.com
IT | $440.38 -2.05% 0.0% 450K
|
Commercial Services
|
| O: -0.3%
H: 1.31%
C: -1.42%
gartner positive
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
Published: 2022-06-07 (Crawled : 12:00) - adnas.com
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: -6.09%
H: 3.26%
C: -11.26%
preclinical vaccine positive cancer pre-clinical
Kyndryl Positioned as a Leader in 2022 Gartner® Magic Quadrant™ for Managed Mobility Services, Global
Published: 2022-05-23 (Crawled : 13:20) - prnewswire.com
KD | $19.66 0.1% 0.0% 1.5M
|
Information
|
| O: -2.19%
H: 0.43%
C: -4.78%
IT | $440.38 -2.05% 0.0% 450K
|
Commercial Services
|
| O: 0.41%
H: 0.0%
C: 0.0%
gartner positive
Zscaler Positioned as a Leader in the 2022 Gartner® Magic Quadrant™ for Security Service Edge (SSE)
Published: 2022-02-18 (Crawled : 17:00) - globenewswire.com
IT | $440.38 -2.05% 0.0% 450K
|
Commercial Services
|
| O: -0.3%
H: 2.02%
C: 0.91%
ZS | $169.23 -2.16% -2.21% 2.3M
|
Technology Services
|
| O: 0.98%
H: 0.0%
C: -3.52%
gartner security one positive
APDN, EvviVax Announce Publication of Positive Preclinical Data for Linear DNA™ Platform Approach to Cancer Immunotherapy
Published: 2022-02-17 (Crawled : 17:00) - adnas.com
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: -1.01%
H: 2.03%
C: -3.05%
preclinical immunotherapy positive therapy cancer platform pre-clinical
Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy
Published: 2022-02-17 (Crawled : 14:30) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: -1.01%
H: 2.03%
C: -3.05%
preclinical immunotherapy positive therapy cancer platform pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.